Semble raises £30m Series C to scale AI care orchestration platform across UK and Europe

UK healthcare technology company Semble has secured £30 million in a Series C funding round to accelerate the expansion of its clinical care orchestration platform across the UK and into European markets, as private outpatient providers face mounting pressure to consolidate fragmented operational systems.

As reported by Partech Partners, the round was led by European growth investor Revaia, with new investor Partech joining alongside continued backing from existing investors Mercia Ventures and Octopus Ventures. More than 10 million patients, approximately one in six people in the UK, have received care from a clinician using the Semble platform. The company's 1,700 customers include Nuffield Health, Welbeck, Midland Health, London Doctors Clinic, Modality and ProblemShared.

CEO and co-founder Christoph Lippuner said the funding will allow the company to scale a fundamentally different approach to healthcare technology. "For years, the industry has tried to address complex systemic issues through disconnected point solutions, but fragmented technology often adds operational complexity for healthcare providers and creates an interrupted experience for patients. What healthcare organisations need is intelligent orchestration across the entire care journey."

Lippuner added that the practices and groups best positioned for the next decade will be those delivering the strongest end-to-end patient experience, and that the Series C enables Semble to rapidly scale that vision across the UK and Europe.

Revaia partner Morgan Kessous said the firm's conviction in Semble is rooted in the platform's clinical depth and market position. "Semble is building the system of action for modern healthcare, a platform with genuine clinical depth, real scale and the trust of healthcare providers across the UK and France. The European healthcare market is being reshaped by technology, by demand and by shifting patient expectations, and Semble is exceptionally well positioned to lead it."

Get the full details of Semble's Series C raise and European expansion strategy in the complete coverage.